JAN 21, 2020 2:57 PM PST

Repurposing Existing Drugs to Treat Cancer

WRITTEN BY: Carmen Leitch

Even after the complicated task of drug development, pharmaceuticals have to be rigorously tested before they can be offered to patients, so it can be much easier to find more than one application for an existing medication. Scientists have now tested a wide variety of drugs that are used to treat many different conditions to see if they had any anti-cancer effect. They were surprised to find that nearly fifty of the ones they assessed, including drugs for alcoholism, diabetes, inflammation, and pet medication for arthritis, exhibited anti-cancer activity that was previously unknown. The work has been reported in Nature Cancer.

"We thought we'd be lucky if we found even a single compound with anti-cancer properties, but we were surprised to find so many," said Professor Todd Golub, chief scientific officer and director of the Cancer Program at the Broad Institute of MIT and Harvard, and Charles A. Dana Investigator in Human Cancer Genetics at Dana-Farber.

This work utilized a collection of around 6,000 drugs that have either been proven to be safe in clinical trials or are approved by the Food and Drug Administration; it's called the Drug Repurposing Hub. The researchers tagged 578 human cancer cell lines with DNA barcodes so the vast number of cells could be pooled and exposed to the many medications. The survival rate of the various cancer cells was measured so the investigators could determine which of the drugs kill cancer.

"We created the repurposing hub to enable researchers to make these kinds of serendipitous discoveries in a more deliberate way," said the first author of the study Steven Corsello, an oncologist at Dana-Farber and founder of the Drug Repurposing Hub.

The researchers discovered the anti-cancer activity of fifty drugs, some of which killed selectively, while others destroyed cancer cells in surprising ways.

"Most existing cancer drugs work by blocking proteins, but we're finding that compounds can act through other mechanisms," said Corsello. Some of these drugs don't work by interfering with a protein; they stabilize a chemical interaction or activate a protein, for example. This cell-survival-based approach made identifying these mechanisms easier, said Corsello.

Image credit: Pixabay

In another case, cancer cells were killed by drugs that interacting with something unknown. For example, tepoxalin is used to treat osteoarthritis in dogs, and this anti-inflammatory medication kills cancer after acting on an unknown target in cells that express high levels of a protein called MDR1.

Genetic characteristics like methylation levels and mutations in the cancer cell lines enabled the researchers to predict which drugs would kill them. For example, cells that carried mutations that reduced their metallothionein protein levels were killed by a drug for alcohol dependence, called Antabuse. If cells expressed a certain sulfate transporter called SLC26A2, they were susceptible to drugs that contain vanadium.

"The genomic features gave us some initial hypotheses about how the drugs could be acting, which we can then take back to study in the lab," said Corsello. "Our understanding of how these drugs kill cancer cells gives us a starting point for developing new therapies. This is a great initial dataset, but certainly, there will be a great benefit to expanding this approach in the future."

Sources: AAAS/Eurekalert! via Broad Institute of MIT and Harvard, Nature Cancer

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 21, 2021
Cell & Molecular Biology
A Model of Early Human Development is Created
MAR 21, 2021
A Model of Early Human Development is Created
Scientists now have a new way to investigate the processes underlying human development, diseases that may arise during ...
MAR 24, 2021
Genetics & Genomics
Some 'Zombie' Genes Ramp Up Activity in the Brain After Death
MAR 24, 2021
Some 'Zombie' Genes Ramp Up Activity in the Brain After Death
The brain is an organ that needs oxygen to survive, but it's been known that some brain cells can remain active afte ...
APR 06, 2021
Cell & Molecular Biology
New Insight Into a Crucial Immune Cell
APR 06, 2021
New Insight Into a Crucial Immune Cell
Dendritic cells are a crucial part of the immune response; they look out for the presence of pathogenic invaders like vi ...
APR 18, 2021
Cell & Molecular Biology
Controlling the Epigenome with CRISPRoff & CRISPRon
APR 18, 2021
Controlling the Epigenome with CRISPRoff & CRISPRon
Some parts of the genome are simple; many genes encode for proteins, and if there is an error in one of those protein-co ...
MAY 06, 2021
Cell & Molecular Biology
Improved Genetic Technologies Find Elusive Genetic Mutations
MAY 06, 2021
Improved Genetic Technologies Find Elusive Genetic Mutations
Some genetic diseases are caused by inborn errors - genetic mutations that we're born with and that end up in every cell ...
MAY 10, 2021
Cell & Molecular Biology
Getting RNA-Based Medicine Past the Blood-Brain Barrier
MAY 10, 2021
Getting RNA-Based Medicine Past the Blood-Brain Barrier
RNA molecules serve several functions, one of which is to help the cell generate proteins from active genes. It also may ...
Loading Comments...